T2 Biosystems to Host Business Update Call on October 10, 2024
T2 Biosystems to Host Business Update Call on October 10, 2024
LEXINGTON, Mass., Oct. 08, 2024 (GLOBE NEWSWIRE) -- T2 Biosystems, Inc. (NASDAQ:TTOO), a leader in the rapid detection of sepsis-causing pathogens and antibiotic resistance genes, announced today that it will host a business update call to provide additional details on recent developments after market close at 4:30pm ET on Thursday October 10, 2024. On the call management also plans to address select questions from shareholders that can be submitted in advance to the investor relations team at ir@T2Biosystems.com.
馬薩諸塞州列剋星敦，2024年10月08日，T2生物系統公司（納斯達克代碼：TTOO）是臨床感染性疾病病原體及抗生素耐藥基因快速檢測的領導者，今日宣佈將在2024年10月10日星期四下午4:30pm Et市場收盤後舉行業務更新電話會議。在通話中，管理團隊還計劃回答股東事先通過ir@T2Biosystems.com投資者關係團隊提交的部分問題。
Investors interested in listening to the conference call may do so by accessing a live and archived webcast of the event at , on the Investors page in the Events & Presentations section. To listen to the conference call, please dial 1-888-506-0062 (US/Canada) or 1-973-528-0011 (International), passcode 702677, approximately ten to five minutes prior to the start time.
對於有興趣收聽電話會議的投資者，可以通過訪問活動的現場直播和存檔網絡傳輸，地址爲，在投資者頁面的事件與演示部分。要收聽電話會議，請於開始時間前約十至五分鐘撥打1-888-506-0062（美國/加拿大）或1-973-528-0011（國際），密碼爲702677。
About T2 Biosystems
T2 Biosystems, a leader in the rapid detection of sepsis-causing pathogens and antibiotic resistance genes, is dedicated to improving patient care and reducing the cost of care by helping clinicians effectively treat patients faster than ever before. T2 Biosystems' products are powered by the proprietary T2 Magnetic Resonance (T2MR) technology and include the T2Dx Instrument, the T2Bacteria Panel, the T2Candida Panel, the T2Resistance Panel, and the T2Biothreat Panel. T2 Biosystems has an active pipeline of future products, including the U.S. T2Resistance Panel, the T2Lyme Panel, and the expended T2Candida Panel to add the detection of Candida auris. For more information, please visit .
t2 biosystems簡介
T2 Biosystems是全球菌血症病原體和抗生素耐藥基因快速檢測領域的領導者，致力於通過幫助臨床醫生更快有效地治療患者來提高患者護理質量並降低護理成本。T2 Biosystems的產品採用專有的T2磁共振（T2MR）技術，幷包括T2Dx儀器、T2Bacteria面板、T2Candida面板、T2Resistance面板和T2Biothreat面板。T2 Biosystems正在積極開發未來的產品，包括美國T2Resistance面板、T2Lyme面板和擴展的T2Candida面板以檢測Candida auris。欲了解更多信息，請訪問。
Investor Contact:
Philip Trip Taylor, Gilmartin Group
ir@T2Biosystems.com
415-937-5406
投資者聯繫人：
Philip Trip Taylor，Gilmartin Group
ir@T2Biosystems.com
415-937-5406
Source: T2 Biosystems, Inc.
來源：T2 Biosystems, Inc。
譯文內容由第三人軟體翻譯。
